Stefania Madonna
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
CXCL13 as a simple and promising blood biomarker for differentiating Sézary syndrome from mycosis fungoides and other confounding chronic inflammatory skin diseases.
Journal: Frontiers in immunology
Published: February 04, 2026
Genetic profiling of patients with atopic dermatitis reveals immune and skin barrier variants associated with generalized eczema and optimal response to Dupilumab therapy.
Journal: Frontiers in immunology
Published: January 15, 2026
Mutational profile of atypical fibroxanthoma and pleomorphic dermal sarcoma further expands the spectrum of genomic alterations in rare cutaneous neoplasms.
Journal: Scientific reports
Published: December 28, 2025
Targeting serine/glycine metabolism to attenuate IFN-γ- and IL-22-driven inflammation and hyperproliferation in psoriasis.
Journal: Cell death discovery
Published: December 18, 2025
TRPA1 as a Key Regulator of Keratinocyte Homeostasis and Inflammation in Human Skin.
Journal: Cells
Published: December 11, 2025
Hidradenitis suppurativa: epidemiology, diagnosis, molecular pathogenesis and therapy.
Journal: Molecular biomedicine
Published: October 31, 2025
Synthesis, Biological Evaluation, and Computational Study of Pyridine- and Indazole-Based Inhibitors of the Inducible Nitric Oxide Synthase as Promising Antipsoriatic Agents.
Journal: ACS pharmacology & translational science
Published: October 27, 2025
Unmasking the High Prevalence of Psychological Morbidity in Atopic Dermatitis-A Call for Routine Screening.
Journal: International journal of dermatology
Published: October 20, 2025
Anti-IL-17 and Anti-IL-23 Therapies Modulate Serum Biomarkers of Intestinal Dysbiosis and Oxidative Stress Linked to Cardiovascular Risk in Patients with Psoriasis.
Journal: Life (Basel, Switzerland)
Published: October 01, 2025
Leptin: a gender and obesity-related marker predictive of metabolic comorbidities and therapeutic response to anti-IL-23 biologic drugs in psoriatic patients.
Journal: Frontiers in immunology
Published: April 07, 2025
Nerve growth factor receptor p75NTR interacts with Toll-like receptor 4 and the alarmins high mobility group box 1 and nucleophosmin: a novel inflammatory mechanism in psoriasis.
Journal: The British journal of dermatology
Published: February 27, 2025
Beyond the skin: endocrine, psychological and nutritional aspects in women with hidradenitis suppurativa.
Journal: Journal of translational medicine
Published: December 09, 2024
Last Updated: 09/26/2026